How do I buy Fennec Pharmaceuticals (FENC) stock?

You can purchase shares of Fennec Pharmaceuticals (NASDAQ:FENC) through any online brokerage.View our list of the best stock brokerages

Who are Fennec Pharmaceuticals (FENC) competitors?

Other companies in Fennec Pharmaceuticals’s space includes: Humacyte Inc (NASDAQ:HUMA), Galectin Therapeutics Inc (NASDAQ:GALT), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL), Voyager Therapeutics Inc (NASDAQ:VYGR) and Larimar Therapeutics Inc (NASDAQ:LRMR).

What is the forecast, or price target, for Fennec Pharmaceuticals (FENC) stock?

Fennec Pharmaceuticals has a consensus price target of $15.25.

What is the current price for Fennec Pharmaceuticals (FENC)?

The stock price for Fennec Pharmaceuticals (NASDAQ: FENC) is $7.59 last updated January 16, 2026 at 4:00 PM EST.

Does Fennec Pharmaceuticals (FENC) pay a dividend?

There are no upcoming dividends for Fennec Pharmaceuticals.

When is Fennec Pharmaceuticals (NASDAQ:FENC) reporting earnings?

Fennec Pharmaceuticals does not have any upcoming earnings scheduled.

Is Fennec Pharmaceuticals (FENC) going to split?

There is no upcoming split for Fennec Pharmaceuticals.

What sector and industry does Fennec Pharmaceuticals (FENC) operate in?

Fennec Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Fennec Pharmaceuticals (FENC) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

Comments